JPH08503230A - 骨の無機質減少疾患の局所的治療を意図した医薬品の製造において、活性成分として、生体親和性でかつ生体吸収性のカルシウム塩の粒子を使用する方法 - Google Patents
骨の無機質減少疾患の局所的治療を意図した医薬品の製造において、活性成分として、生体親和性でかつ生体吸収性のカルシウム塩の粒子を使用する方法Info
- Publication number
- JPH08503230A JPH08503230A JP6525070A JP52507094A JPH08503230A JP H08503230 A JPH08503230 A JP H08503230A JP 6525070 A JP6525070 A JP 6525070A JP 52507094 A JP52507094 A JP 52507094A JP H08503230 A JPH08503230 A JP H08503230A
- Authority
- JP
- Japan
- Prior art keywords
- bone
- use according
- calcium salt
- biocompatible
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/025—Other specific inorganic materials not covered by A61L27/04 - A61L27/12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3616—Blood, e.g. platelet-rich plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/365—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/10—Mineral substrates
- C12N2533/18—Calcium salts, e.g. apatite, Mineral components from bones, teeth, shells
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.骨の無機質減少または鉱化欠損に関する疾患の局所的治療のための医薬品の 製造において、特に吸収された骨スパンの無機質成分再補充および再構成の過程 を再開始させるために、少なくとも1種の生体親和性でかつ生体吸収性のカルシ ウム塩を、8mm未満の寸法を有する粒子の形状で、活性成分として使用する方法 。 2.前記疾患が、骨粗鬆症、ページェット病、線維性異形成症および骨形成異常 である請求項1記載の使用方法。 3.前記医薬品が、骨の海綿部分または髄管に移植されることを意図されている 請求項1または2記載の使用方法。 4.前記カルシウム塩が、グルコン酸塩、酒石酸塩、グリセロリン酸塩、硫酸塩 、炭酸塩およびリン酸塩の中から選択される請求項1〜3のいずれか1項記載の 使用方法。 5.前記カルシウム塩が炭酸塩である請求項1〜4のいずれか1項記載の使用方 法。 6.前記炭酸塩が、アラゴナイトまたは方解石の形である請求項1〜5のいずれ か1項記載の使用方法。 7.前記炭酸塩が、サンゴ骨格、棘皮動物骨格または軟体動物の殻由来のもので ある請求項1〜6のいずれか1項記載の使用方法。 8.活性成分が、リン酸塩を含まない請求項1〜7のいずれか1項記載の使用方 法。 9.前記粒子が、5mm未満の寸法、特に0.2〜4mmの寸法 を有する請求項1〜8のいずれか1項記載の使用方法。 10.骨組織発生を促進する、および/または前記粒子を流動性ペースト状にする ことができる物質少なくとも1種と、前記粒子が混合される請求項1〜9のいず れか1項記載の使用方法。 11.前記物質が、ストロンチウム塩、フッ化物、成長因子、血液、血漿、骨髄、 コラーゲン、生物的接着剤および生体親和性ゲル化剤から選択される請求項10記 載の使用方法。 12.カルシウム塩が、医薬品の総重量に対して40〜100重量%である請求項1〜1 1のいずれか1項記載の使用方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9305783A FR2705235B1 (fr) | 1993-05-13 | 1993-05-13 | Utilisation de particules d'un sel de calcium biocompatible et biorésorbable comme ingrédient actif dans la préparation d'un médicament destiné au traitement local des maladies déminéralisantes de l'os. |
FR93/05783 | 1993-11-17 | ||
PCT/FR1994/000564 WO1994026283A1 (fr) | 1993-05-13 | 1994-05-11 | Utilisation de particules d'un sel de calcium biocompatible et bioresorbable comme ingredient actif dans la preparation d'un medicament destine au traitement local des maladies demineralisantes de l'os |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08503230A true JPH08503230A (ja) | 1996-04-09 |
JP3021049B2 JP3021049B2 (ja) | 2000-03-15 |
Family
ID=9447095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6525070A Expired - Fee Related JP3021049B2 (ja) | 1993-05-13 | 1994-05-11 | 骨の無機質減少疾患の局所的治療を意図した医薬品の製造において、活性成分として、生体親和性でかつ生体吸収性のカルシウム塩の粒子を使用する方法 |
Country Status (12)
Country | Link |
---|---|
US (1) | US5618549A (ja) |
EP (1) | EP0649309B1 (ja) |
JP (1) | JP3021049B2 (ja) |
AT (1) | ATE204174T1 (ja) |
AU (1) | AU675137B2 (ja) |
CA (1) | CA2139865C (ja) |
DE (1) | DE69427947T2 (ja) |
DK (1) | DK0649309T3 (ja) |
ES (1) | ES2163442T3 (ja) |
FR (1) | FR2705235B1 (ja) |
PT (1) | PT649309E (ja) |
WO (1) | WO1994026283A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010525070A (ja) * | 2007-04-23 | 2010-07-22 | バクスター・インターナショナル・インコーポレイテッド | ストロンチウム化合物を含むフィブリン組成物 |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040081704A1 (en) * | 1998-02-13 | 2004-04-29 | Centerpulse Biologics Inc. | Implantable putty material |
GB9823307D0 (en) | 1998-10-23 | 1998-12-23 | Regent Genus Organisms Interna | Composition for traetment of periodontopathy and related diseases |
AU1525700A (en) | 1998-11-19 | 2000-06-05 | Board Of Trustees Of The University Of Arkansas, The | Increasing bone strength with selected bisphosphonates |
US7371408B1 (en) * | 1999-06-07 | 2008-05-13 | Wright Medical Technology, Inc. | Bone graft substitute composition |
US6630153B2 (en) * | 2001-02-23 | 2003-10-07 | Smith & Nephew, Inc. | Manufacture of bone graft substitutes |
US6372198B1 (en) | 2000-09-14 | 2002-04-16 | Joseph M. Abbate | Dentifrice for the mineralization and remineralization of teeth |
US20020114795A1 (en) | 2000-12-22 | 2002-08-22 | Thorne Kevin J. | Composition and process for bone growth and repair |
EP1492475B1 (en) * | 2001-04-16 | 2011-12-21 | Wright Medical Technology, Inc. | Dense/porous structures for use as bone substitutes |
US7371409B2 (en) | 2001-09-06 | 2008-05-13 | Wright Medical Technology, Inc. | Bone graft substitute composition |
ATE490745T1 (de) | 2002-03-29 | 2010-12-15 | Wright Medical Tech Inc | Knochentransplantat-ersatzzusammensetzung |
US6652887B1 (en) | 2002-06-24 | 2003-11-25 | Wright Medical Technology, Inc. | Bone graft substitute composition |
US7291179B2 (en) | 2002-06-24 | 2007-11-06 | Wright Medical Technology, Inc. | Bone graft substitute composition |
FR2850282B1 (fr) | 2003-01-27 | 2007-04-06 | Jerome Asius | Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation |
US7507257B2 (en) * | 2003-02-04 | 2009-03-24 | Wright Medical Technology, Inc. | Injectable resorbable bone graft material, powder for forming same and methods relating thereto for treating bone defects |
US7250550B2 (en) * | 2004-10-22 | 2007-07-31 | Wright Medical Technology, Inc. | Synthetic bone substitute material |
US20060233849A1 (en) * | 2005-04-13 | 2006-10-19 | Simon Bruce J | Composite bone graft material |
US7621963B2 (en) * | 2005-04-13 | 2009-11-24 | Ebi, Llc | Composite bone graft material |
BRPI0617086B8 (pt) | 2005-09-09 | 2021-06-22 | Agnovos Healtcare Llc | cimento composto substituto de enxerto ósseo e artigos dele originados |
US8025903B2 (en) * | 2005-09-09 | 2011-09-27 | Wright Medical Technology, Inc. | Composite bone graft substitute cement and articles produced therefrom |
BRPI0712910B8 (pt) * | 2006-05-26 | 2021-05-25 | Baxter Int | sistema de múltiplos componentes para uma composição de aumento ósseo injetável, e, composição de aumento ósseo injetável |
DE102006037362B3 (de) | 2006-08-09 | 2007-09-20 | Heraeus Kulzer Gmbh | Knochenersatzmaterial |
US7718616B2 (en) | 2006-12-21 | 2010-05-18 | Zimmer Orthobiologics, Inc. | Bone growth particles and osteoinductive composition thereof |
WO2009006921A1 (en) * | 2007-07-10 | 2009-01-15 | Barrera Jose Bouza | Microporous material for surgical implant |
EP2501281B1 (en) * | 2009-11-20 | 2019-10-30 | Zimmer Knee Creations, Inc. | Coordinate mapping system for joint treatment |
WO2011063260A1 (en) | 2009-11-20 | 2011-05-26 | Knee Creations, Llc | Bone-derived implantable devices for subchondral treatment of joint pain |
WO2011063257A1 (en) | 2009-11-20 | 2011-05-26 | Knee Creations, Llc | Instruments for targeting a joint defect |
WO2011063240A1 (en) | 2009-11-20 | 2011-05-26 | Knee Creations, Llc | Implantable devices for subchondral treatment of joint pain |
KR20120101079A (ko) | 2009-11-20 | 2012-09-12 | 니 크리에이션스, 엘엘씨 | 관절에 대한 가변 각도 접근을 위한 기기 |
US8821504B2 (en) | 2009-11-20 | 2014-09-02 | Zimmer Knee Creations, Inc. | Method for treating joint pain and associated instruments |
US8951261B2 (en) * | 2009-11-20 | 2015-02-10 | Zimmer Knee Creations, Inc. | Subchondral treatment of joint pain |
CN102781348B (zh) | 2009-11-20 | 2015-07-15 | 膝部创造物有限责任公司 | 用于关节修复的导航和定位仪器 |
TWI579007B (zh) | 2010-07-02 | 2017-04-21 | 艾格諾福斯保健公司 | 骨再生材料之用途 |
JP2013542837A (ja) | 2010-11-15 | 2013-11-28 | ジンマー オーソバイオロジクス,インコーポレイティド | 骨空隙充填剤 |
US10478309B2 (en) | 2014-01-10 | 2019-11-19 | Mbp (Mauritius) Ltd | Method for producing osteosynthesis devices, osteosynthesis devices and implants made of semi-synthetic hybrid material obtained by structural modification of the components of a natural marine biomaterial |
CA3065666C (en) | 2017-06-01 | 2024-04-09 | Fundacio Institut De Bioenginyeria De Catalunya (Ibec) | Controllable ion release calcium particles, method for producing same and use thereof |
RU2676478C1 (ru) * | 2017-10-12 | 2018-12-29 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации | Способ приготовления пломбировочной массы для закрытия дефекта кости |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT359652B (de) * | 1979-02-15 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines gewebekleb- stoffes |
FR2460657A1 (fr) * | 1979-07-12 | 1981-01-30 | Anvar | Implant biodegradable utilisable comme piece de prothese osseuse |
US4440750A (en) * | 1982-02-12 | 1984-04-03 | Collagen Corporation | Osteogenic composition and method |
US4789663A (en) * | 1984-07-06 | 1988-12-06 | Collagen Corporation | Methods of bone repair using collagen |
DE3433210C1 (de) * | 1984-09-10 | 1986-06-05 | Hans Dr.med. Dr.med.dent. 8000 München Scheicher | Mittel zur Fuellung von Knochen- und Zahndefekten,zum Knochenaufbau,fuer Knochenkontaktschichten und fuer Knochen- und Zahnwurzelersatz und Verwendung von Carbonatapatit fuer diesen Zweck |
DE3542744C1 (de) * | 1985-12-03 | 1987-05-27 | Ewers Rolf | Poroeses Hydroxylapatit-Material |
US4743229A (en) * | 1986-09-29 | 1988-05-10 | Collagen Corporation | Collagen/mineral mixing device and method |
US5085861A (en) * | 1987-03-12 | 1992-02-04 | The Beth Israel Hospital Association | Bioerodable implant composition comprising crosslinked biodegradable polyesters |
WO1989006944A1 (fr) * | 1988-01-26 | 1989-08-10 | Thierry Rainier Besins | Systeme de formation de depots subperiostaux pour restauration faciale |
FR2637502A1 (fr) * | 1988-10-12 | 1990-04-13 | Duroselle Patrick | Materiau de xenogreffe osseuse et procede d'obtention |
US4976736A (en) * | 1989-04-28 | 1990-12-11 | Interpore International | Coated biomaterials and methods for making same |
DE69027061T2 (de) * | 1989-06-30 | 1997-01-02 | Tdk Corp | Ersatzmaterial für lebende Hartgewebe, seine Herstellung und Herstellung eines Formkörpers |
US5158934A (en) * | 1989-09-01 | 1992-10-27 | Genentech, Inc. | Method of inducing bone growth using TGF-β |
US5071655A (en) * | 1990-01-12 | 1991-12-10 | Baylink David J | Pharmaceutical combination for treatment of bone-wasting diseases |
-
1993
- 1993-05-13 FR FR9305783A patent/FR2705235B1/fr not_active Expired - Fee Related
-
1994
- 1994-05-11 US US08/360,823 patent/US5618549A/en not_active Expired - Lifetime
- 1994-05-11 DK DK94916274T patent/DK0649309T3/da active
- 1994-05-11 CA CA002139865A patent/CA2139865C/fr not_active Expired - Fee Related
- 1994-05-11 AT AT94916274T patent/ATE204174T1/de active
- 1994-05-11 WO PCT/FR1994/000564 patent/WO1994026283A1/fr active IP Right Grant
- 1994-05-11 EP EP94916274A patent/EP0649309B1/fr not_active Expired - Lifetime
- 1994-05-11 AU AU67886/94A patent/AU675137B2/en not_active Ceased
- 1994-05-11 ES ES94916274T patent/ES2163442T3/es not_active Expired - Lifetime
- 1994-05-11 DE DE69427947T patent/DE69427947T2/de not_active Expired - Lifetime
- 1994-05-11 PT PT94916274T patent/PT649309E/pt unknown
- 1994-05-11 JP JP6525070A patent/JP3021049B2/ja not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010525070A (ja) * | 2007-04-23 | 2010-07-22 | バクスター・インターナショナル・インコーポレイテッド | ストロンチウム化合物を含むフィブリン組成物 |
Also Published As
Publication number | Publication date |
---|---|
EP0649309A1 (fr) | 1995-04-26 |
AU6788694A (en) | 1994-12-12 |
WO1994026283A1 (fr) | 1994-11-24 |
AU675137B2 (en) | 1997-01-23 |
FR2705235A1 (fr) | 1994-11-25 |
ES2163442T3 (es) | 2002-02-01 |
JP3021049B2 (ja) | 2000-03-15 |
US5618549A (en) | 1997-04-08 |
PT649309E (pt) | 2002-01-30 |
DK0649309T3 (da) | 2001-11-12 |
DE69427947T2 (de) | 2002-04-11 |
CA2139865C (fr) | 2005-08-09 |
DE69427947D1 (de) | 2001-09-20 |
CA2139865A1 (fr) | 1994-11-24 |
EP0649309B1 (fr) | 2001-08-16 |
FR2705235B1 (fr) | 1995-07-13 |
ATE204174T1 (de) | 2001-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3021049B2 (ja) | 骨の無機質減少疾患の局所的治療を意図した医薬品の製造において、活性成分として、生体親和性でかつ生体吸収性のカルシウム塩の粒子を使用する方法 | |
Jones et al. | Bioglass and bioactive glasses and their impact on healthcare | |
Lew et al. | Repair of craniofacial defects with hydroxyapatite cement | |
US6287341B1 (en) | Orthopedic and dental ceramic implants | |
Costantino et al. | Hydroxyapatite cement: I. Basic chemistry and histologic properties | |
Shindo et al. | Facial skeletal augmentation using hydroxyapatite cement | |
JP4781494B2 (ja) | 不完全結晶性カルシウムホスフェートの製造法及びその使用法 | |
Grundel et al. | Autogeneic bone marrow and porous bipiasic calcium phosphate ceramic for segmental bone defects in the canine ulna | |
JP6412601B2 (ja) | 生体活性代用骨移植片 | |
EP2640429B1 (en) | Bone void fillers | |
US8778378B2 (en) | Bioactive antibacterial bone graft materials | |
US5011495A (en) | Unique bone regeneration tricalcium phosphate | |
Verheggen et al. | Correction of skull defects using hydroxyapatite cement (HAC)–evidence derived from animal experiments and clinical experience | |
CN101466415A (zh) | 含有脱矿质骨基质的软式植入物 | |
EP2080528B1 (en) | Preparation for regeneration of postoperative and post-traumatic bone defects | |
US20020136696A1 (en) | Orthopedic and dental ceramic implants | |
Snyders Jr et al. | Enhancement of repair in experimental calvarial bone defects using calcium sulfate and dextran beads | |
Newsom et al. | Design and evaluation of 3D-printed Sr-HT-Gahnite bioceramic for FDA regulatory submission: A Good Laboratory Practice sheep study | |
WO2010050935A1 (en) | Devices containing demineralized bone matrix particles | |
KR20230043883A (ko) | 철 부형제를 사용하여 골을 이식하는 방법 및 조성물 | |
Hanft et al. | Implantable bone substitute materials | |
EP2307057A1 (en) | Manufacturing method of collagen gel composition for bone regeneration | |
RU2146928C1 (ru) | Состав для стимуляции регенерации костных тканей | |
Cunningham | The use of calcium phosphate cements in the maxillofacial region | |
Abdallah | Comparison for the complication rate with three different materials used in frontal sinus obliteration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090114 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090114 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100114 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100114 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110114 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120114 Year of fee payment: 12 |
|
LAPS | Cancellation because of no payment of annual fees |